NeuroBo Pharmaceuticals Inc (NRBO) - Rasio rega marang prakiraan pendapatan

Logo korporat perusahaan NeuroBo Pharma (NRBO)

NeuroBo Pharmaceuticals is developing innovative treatments for obesity and diabetes, targeting a colossal global market. The expected P/S metric visualizes the dynamics of these prospects, where the value of reflects this status. The US biotech company's developments rely on clinical trials, while its growth strategy is based on finding a niche amidst intense pressure from industry behemoths.

neurobopharma.com - Rega forward marang dodolan NRBO (periode 04.07.2022 - 15.11.2026)

Rincian metrik komprehensif lan analitis neurobopharma.com (NRBO)

- rega saham lan target rega konsensus:
Analisis kabeh metrik perusahaan:NeuroBo Pharmaceuticals Inc NRBO
Produk asli NeuroBo Pharmaceuticals

This metric compares current market capitalization with expected revenue, allowing for an assessment of whether the share price is justified relative to future sales and margin growth rates. By analyzing the forward P/S ratio, an investor can identify the risk of overpaying for NeuroBo Pharmaceuticals (NRBO) if market optimism outpaces actual progress in clinical trials for obesity and liver drugs amid fierce competition.

Pesaing NeuroBo Pharmaceuticals

Multiplikator Forward P/S BIIB (Biogen Idec)|Rasio kapitalisasi marang dodolan sing dikarepake Neurocrine Corp (NBIX)|RGC: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan AXSM (Axsome Therapeutics)|ACAD: Multiplikator Forward P/S|Xenon Pharmaceuticals Inc. - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Viking Pharma|SUPN: Rega forward marang dodolan|Multiplikator Forward P/S CPRX|Multiplikator Forward P/S denalitherapeutics.com (DNLI)|Multiplikator Forward P/S HRMY (Harmony Biosciences Inc)|Rasio kapitalisasi marang dodolan sing dikarepake Biohaven (BHVN)|Amylyx Corp - Multiplikator Forward P/S|TRVI - Multiplikator Forward P/S|Praxis Precision Medicines Inc (PRAX) - Rasio rega marang prakiraan pendapatan|AVXL - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan CeriBell|Multiplikator Forward P/S Prothena Corporation plc|Rasio rega marang prakiraan pendapatan Alector Therapeutics (ALEC)|Annexon Inc. - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan omeros.com OMER|neurogene.com (NGNE) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|acimmune.com - Multiplikator Forward P/S|Voyager Therapeutics Inc (VYGR) - Multiplikator forward rega marang pendapatan|Neumora Corp (NMRA) - Rasio rega marang prakiraan pendapatan|Scilex Holding Company, Inc. (SCLX) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan TVGN|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Alpha Cognition Inc. ACOG|Rasio rega marang prakiraan pendapatan cogrx.com (CGTX)|Rasio kapitalisasi marang dodolan sing dikarepake Inhibikase Therapeutics, Inc.|Multiplikator Forward P/S SAVA (Cassava Sciences Inc)|Multiplikator Forward P/S Assertio Holdings, Inc. ASRT|COYA - Rasio rega marang prakiraan pendapatan|Prakiraan rega marang pendapatan Vistagen (VTGN)|OVID: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Acumen Pharmaceuticals Inc. (ABOS)|Multiplikator forward rega marang pendapatan CRVO|Kapitalisasi marang prakiraan pendapatan ATHE (Alterity Therapeutics)|Rasio rega marang prakiraan pendapatan Clene Nanomedicine (CLNN)|PEPG (PepGen) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Jupiter Neurosciences Inc JUNS|Rega forward marang dodolan RLMD|ANVS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Grace Therapeutics Inc|AIFF: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Klotho Neurosciences Inc (KLTO)|Rasio rega marang prakiraan pendapatan neurosense-tx.com|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Reviva Pharmaceuticals Holdings Inc. RVPH|Rasio rega marang prakiraan pendapatan MetaVia Inc. (MTVA)|Rasio kapitalisasi marang dodolan sing dikarepake NeurAxis Inc|Multiplikator Forward P/S HSDT (heliusmedical.com)|Rega forward marang dodolan PASG|NEUP: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Minerva Neurosciences Inc|Athira Pharma (ATHA) - Rasio rega marang prakiraan pendapatan|Addex Therapeutics, Ltd. - Rega forward marang dodolan|ALZN (Alzamend Neuro) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep cyclerion.com CYCN|Multiplikator Forward P/S PTIX|KTTA - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S CRGT (Cortigent, Inc.)|Avenue Therapeutics Inc (ATXI) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|BCLI - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep caratherapeutics.com|CHRO: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Eliem Therapeutics (ELYM)|ITCI (Intra-Cellular Therapies Inc.) - Multiplikator Forward P/S|Multiplikator Forward P/S Longboard|Multiplikator Forward P/S MRNS|Rasio kapitalisasi marang dodolan sing dikarepake nkgenbiotech.com|Multiplikator Forward P/S SAGE (Sage Therapeutics Inc)|Rasio kapitalisasi marang dodolan sing dikarepake Synaptogenix Inc. (SNPX)|TRVN - Rasio rega marang prakiraan pendapatan|vigilneuro.com (VIGL) - Multiplikator forward rega marang pendapatan|WENA: Multiplikator Forward P/S|Cerevel Therapeutics, Inc. (CERE) - Multiplikator Forward P/S